THE SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION IN THE DEVELOPMENT OF CHRONIC KIDNEY DISEASES
Main Article Content
Abstract
it is known that early manifestation of endothelial dysfunction has prognostic significance and is being studied by many foreign and local researchers, including that it occupies one of the leading positions in the structure of morbidity in patients with kidney pathology.
The article presents reasonable opinions about the importance of endothelial dysfunction in the development of chronic kidney diseases.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1. Botyushin M.M., Dmitrieva O.V. Calculation methods for predicting the risk of analgesic interstitial damage //Ter. Arch., 2016. – №6. – P.62-65.
2. Ratner M.Ya., Brodsky M.A., Zubkin M.L. Tubulointerstitial component of chronic glomerulonephritis: clinical and functional diagnostics // Ter. Arch., 2019. – №6. – P.12-15.
3. Bokarev I. N., Bondar I.A., Klimontov V.V., Nadeev A.P. Urinary excretion of anti-inflammatory cytokines and growth factor-converting enzyme in the early stages of diabetic nephropathy //Ter. Arch., 2018. –№1. – P.52–56.
4. Molchanova E.A., Valov A.L. The results of creating a register of chronic kidney failure in patients // Nephrology and dialysis, 2017. – №3. – Р.221-225.
5. Kamyshova E.S., Shvetsov M.Yu., Kutyrina I.M., Burdennyy A.M., Zheng A., Nosikov V.V., Bobkova I.N. Clinical significance of polymorphic markers of TNF, IL-6 and IL-10 genes in chronic glomerulonephritis. Therapeutic Archives, 2016. – №88(6). – Р.45‑50.
6. Bobkova I.N., Kozlovskaya L.V., Rameeva A.S. The clinical significance of determining markers of endothelial dysfunction and angiogenesis factors in urine in the assessment of tubulointerstitial fibrosis in chronic glomerulonephritis // Ter. arch., 2017. – №6. – Р.10-15.
7. Komarova O.V. Biomarkers in chronic kidney disease: a review // Kidney Int., 2017. –Vol. 80, №8. – P.806-821.
8. Kutyrina I.M., Rudenko T.E., Shvetsov M.Yu. Kidney failure as a factor of “aging of blood vessels” // Ter.arch., 2017. –№6. – Р.49-52.
9. Ko Y.C., Mukaida N., Ishiyama S., Tokue A., Kawai T., Matsushima K., Kasahara T. // Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun., 2015. – Apr; –№ 61(4). – P.1307-1314.
10. Abel ED, Atkins RC, Briganti EM, Lewis JB. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy // Am. J. Kidney Dis., 2017. –Vol. 12. –№ 45(2). – P.281-287.